Press release
Global Live Biotherapeutic and Microbiome Contract Manufacturing Market | Quay Pharmaceuticals (UK), Cobra Biologics Limited (UK), Cerbios-Pharma SA (Switzerland), List Biological Labs, Inc. , Arranta Bio , BacThera, 4D pharma plc, Capsugel, Deerland Prob
Request for Sample Pages: https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
According to the latest research study by InsightAce Analytic, the global Live Biotherapeutic and microbiome contract manufacturing market is valued at US$ 19.87 million in 2020, and it is expected to reach US$ 635.9 million by 2030 with a CAGR of 47.54% during a forecast period. By region, Europe dominated the market with a share of 58% in 2020.
Live Biotherapeutic are biological products that contain live organisms and are used to prevent, cure or treat, a disease or condition of human beings. The microbiome is the cluster of microbes living together in the human body. These microbiomes are commonly present in the gut, skin, mouth, and vagina. It is a foundation for several novel therapies.
The rise in the number of various chronic diseases, a growing number of deals among different developers for contract manufacturing, R&D activities to develop manufacturing capabilities related to microbiome-based therapies, increasing approvals for novel therapies are expected to offer immense growth opportunities for the market during the forecast period. Currently, more than 200 companies are innovating microbiome-based therapies to treat various diseases. In addition, leading pharmaceutical companies are also associating with smaller business entities to develop biotherapeutic products and manufacturing facilities. Hence, such initiatives by market players are anticipated to boost market growth in the upcoming years.
However, the lack of sufficient manufacturing capacity, batch-to-batch reliability-related concerns, lack of expertise and infrastructure to handle anaerobic microbial strains may hamper the market growth in the coming years.
Geographically, Europe dominated the market in 2020 and is expected to dominate over the forecast years, followed by North America owing to the well-established healthcare infrastructure and increasing M&A activities by market players in this region.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
Major market players operating in the Live Biotherapeutic and microbiome contract manufacturing market include Quay Pharmaceuticals (UK), Cobra Biologics Limited (UK), Cerbios-Pharma SA (Switzerland), List Biological Labs, Inc. (the US), Arranta Bio (US), BacThera (Switzerland), 4D pharma plc (UK), Capsugel (US), Deerland Probiotics & Enzymes (Georgia), Paragon Bioservices (US), UAS Labs (US), Biose (France), BiomX Inc. (Israel), Wacker Biotech (Germany) among others.
Some of the major developments in the market are as follows:
• In December 2020, Quay Pharma (UK), a UK-based CDMO, extended its presence in the United States with a greater Boston facility, securing a 55,000 sq ft facility for pharmaceutical development and clinical manufacturing. The Greater Boston facility is one of the first facilities established in the US to develop and manufacture live biotherapeutic finished dosages. And Quay is the first company to support this type of manufacture for microbiome-based medicines in both Europe and the US.
• In September 2020, BiomX Inc. (Israel), a company developing natural and engineered phage therapies, collaborated with Boehringer Ingelheim to identify biomarkers associated with patient phenotypes in inflammatory bowel disease (IBD), using the BiomX XMarker microbiome-based biomarker discovery platform.
• In April 2018, Quay Pharma (UK) established specialist GMP suites at its facility in Deeside, Flintshire, as part of an investment in their live biotherapeutics services.
Curious about this most recent version of the report? Obtain Report Details @ https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
Market Segments
Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Product Manufactured, 2020-2030 (Value US$ Mn)
• APIs
• FDFs
Global Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Type of Formulation, 2020-2030 (Value US$ Mn)
• Solid Formulations
• Oral Liquids
• Injectables
• Others
Global Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Company Size, 2020-2030 (Value US$ Mn)
• Large Companies
• Small-sized Companies
• Mid-sized Companies
Global Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Scale of Operation, 2020-2030 (Value US$ Mn)
• Commercial Scale Operations
• Clinical Scale Operations
• Preclinical Scale Operations
Global Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Region, 2020-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Live Biotherapeutic and Microbiome Contract Manufacturing Market, by Country, 2020-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Live Biotherapeutic and microbiome contract manufacturing market
To receive an industry overview and future trends in the Live Biotherapeutic and microbiome contract manufacturing market
To analyze the Live Biotherapeutic and microbiome contract manufacturing market drivers and challenges
To get information on the Live Biotherapeutic and microbiome contract manufacturing market value (US$ Mn) and forecast to 2030
Significant investments, mergers & acquisitions in the Live Biotherapeutic and microbiome contract manufacturing market industry
For More Information @ https://www.insightaceanalytic.com/report/global-live-biotherapeutic-products-and-microbiome-contract-manufacturing-market-/1152
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Live Biotherapeutic and Microbiome Contract Manufacturing Market | Quay Pharmaceuticals (UK), Cobra Biologics Limited (UK), Cerbios-Pharma SA (Switzerland), List Biological Labs, Inc. , Arranta Bio , BacThera, 4D pharma plc, Capsugel, Deerland Prob here
News-ID: 2442452 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for Bio
Human Plasma Products Market 2023: Industry Future Trends | Takeda, CSL, Grifols …
The Human Plasma Products market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with…
Gene Therapy Products Market | Advantagene, Avalanche Bio, Bluebird Bio, Cellado …
The global gene therapy products market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the gene therapy products market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Bio-based Polymethyl Methacrylate (Bio-PMMA) Market 2023 | Detailed Report
The Bio-based Polymethyl Methacrylate (Bio-PMMA) report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research.
The Bio-based Polymethyl Methacrylate (Bio-PMMA) research report…
Bio Pharma Buffer Market – A comprehensive study by Key Players: Bio-Rad, Lonz …
Latest Market intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Bio Pharma Buffer Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments. The COVID-19 Outbreak-Global Bio Pharma Buffer Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary…
IVIG Market Anticipated a Noteworthy CAGR during 2019-2024 & Companies Included …
A report added to the rich database of Qurate Business Intelligence, titled “World IVIG Market by Product Type, Players and Regions - Forecast to 2024”, provides a 360-degree overview of the Global market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the…
Green & Bio-based Solvents Market Analysis, Demand, & Opportunities till 2023 | …
A latest research report titled as “Green & Bio-based Solvents Market for Paints & Coatings, Printing Inks, Commercial & Domestic Cleaning, Adhesives & Sealants, Pharmaceutical, Cosmetics, and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” has been recently added to the vast portfolio of Market Research Reports Search Engine (MRRSE) online research offerings. This report is a professional and in-depth analysis on the…
